Casabé A R, Sarotto N, Gutierrez C, Bechara A J
División Urología, Hospital Durand, Buenos Aires, Argentina.
IME, Instituto Médico Especializado, Buenos Aires, Argentina.
Int J Impot Res. 2016 Nov;28(6):228-233. doi: 10.1038/ijir.2016.33. Epub 2016 Aug 25.
The malleable prosthetic implant is widely accepted among patients and physicians owing to a lower degree of surgical complexity, its rare mechanic failures and lower cost. We have compared the degree of satisfaction with malleable prosthetic implant in 60 patients, 36 with Spectra (AMS) and 24 with Genesis (Coloplast). For assessment purposes, we implemented the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) satisfaction questionnaire adapted for penile prosthetic implants. The mean age and follow-up was 61.7 years (31-82) and 19.9 months (1-61), respectively. Mean EDITS scores did not indicate superiority of one implant over the other, overall satisfaction index being 77.1% and 75.6% for Genesis and Spectra prosthesis, respectively (P=0.4970). Our results revealed that these two models of malleable prostheses present a high level of satisfaction and confirm that the malleable prosthetic implant is an excellent option to treat patients with ED refractory to medical treatment.
由于手术复杂性较低、机械故障罕见且成本较低,可弯曲性假体植入物在患者和医生中广泛接受。我们比较了60例患者对可弯曲性假体植入物的满意度,其中36例使用Spectra(美国美敦力公司),24例使用Genesis(丹麦科洛普拉斯公司)。为了进行评估,我们采用了适用于阴茎假体植入物的治疗满意度勃起功能障碍量表(EDITS)满意度问卷。平均年龄和随访时间分别为61.7岁(31 - 82岁)和19.9个月(1 - 61个月)。平均EDITS评分并未显示一种植入物优于另一种,Genesis和Spectra假体的总体满意度指数分别为77.1%和75.6%(P = 0.4970)。我们的结果表明,这两种可弯曲性假体模型具有较高的满意度,并证实可弯曲性假体植入物是治疗药物难治性勃起功能障碍患者的极佳选择。